 In a report released today,Yi Chenfrom H.C. Wainwright upgraded Stealth Biotherapeutics MITOResearch Report toBuy, with a price target of5.00. The companys shares closed last Thursday at 1.37, close to its 52-week low of 0.91.Accord 